Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare providers in the US.
This collaboration marks the starting phase of a programme aimed at improving access to the cancer test.
The Quest Diagnostics connectivity system allows US providers to order the test directly.